Newport Beach, CA based ABM is an innovative drug discovery and development company, focusing on small molecule targeted therapy for the potential treatment of brain cancers, including GBM, as well as brain metastasis from melanoma, lung cancer, and breast cancer. ABM was founded in 2015 by a group of biotech and pharmaceutical industry veterans with more than 20 years of experience in the development of neurological drugs and enterprise management in North America.

Learn More about ABM Therapeutics
Read about AceLink Therapeutics